China Health Industries Holdings Inc (CHHE) Return on Equity ROE from the third quarter 2024 to third quarter 2023 and annually, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
China Health Industries Holdings Inc   (NONE: CHHE)

China Health Industries Holdings Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for China Health Industries Holdings Inc in the third quarter 2024?
China Health Industries Holdings Inc recorded a cumulative net loss of $-1 million during 12 months ending in the third quarter 2024, resulting in a negative return on equity (ROE) of -7.45%.

Within the Major Pharmaceutical Preparations industry 67 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2024 from 2260 to 2690.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2024)
III. Quarter		 (Dec 31 2023)
II. Quarter		 (Sep 30 2023)
I. Quarter		 (Jun 30 2023)
IV. Quarter		 (Mar 31 2023)
III. Quarter
Y / Y Equity Change - - -2.88 % -8.63 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -1 -2 0 0 1
Return On Equity (TTM) -7.45 % -5.14 % -0.33 % -1 % 1.69 %
CHHE's Total Ranking # 2690 # 2260 # 2209 # 2283 # 2311
Equity (TTM) in Millions -2 -2 39 39 42
Seq. Equity Change - - -1.08 % -6.7 % -0.27 %
Seq. Net Income Change - - - - -

Back to CHHE Management Effectiveness >> CHHE's 5 Years Annual ROE >> Compare CHHE ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 68
Sector # 220
Overall # 2690

Return On Equity Statistics
High Average Low
10.46 %
2.05 %
-7.45 %
(Mar 31 2020)   (Mar 31 2024)





CHHE Annual Return On Equity (Jun 30 2023)
2023		 (Jun 30 2022)
2022		 (Jun 30 2021)
2021		 (Jun 30 2020)
2020		 (Jun 30 2019)
2019
Total Equity in Millions 39 43 45 40 37
Y / Y Equity Change -8.63 % -4.4 % 12.87 % 6.68 % 5.5 %
Net Income in Millions 0 0 1 4 3
Y / Y Net Income Change - - -63.64 % 7.37 % -
Return On Equity -1.05 % -0.83 % 2.88 % 8.95 % 8.89 %

Back to CHHE Management Effectiveness >> CHHE's 5 Years Annual ROE >> Compare CHHE ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CHHE's' Return on Equity at Yahoo Finance
CHHE's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CHHE's Competitors
Subscribers only: Roe for China Health Industries Holdings Inc 's Suppliers
Subscribers only: Return On Equity for CHHE's Customers




Companies with similar Return On Equity at Mar 31 2024, within Healthcare Sector ROE

Date modified: 2026-09-08T15:11:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.